Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients (CHART)
This study is currently recruiting participants.
Verified August 2013
by Questcor Pharmaceuticals, Inc.
Study NCT01386554 Information provided by Questcor Pharmaceuticals, Inc.
First Received on June 29, 2011. Last Updated on August 12, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Membranous Nephropathy
Additional conditions recognized in this trial
More general conditions related to this trial
Immune System Diseases
Signs and Symptoms
Interventions listed in this trial
Repository Corticotropin Injection
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Sponsors listed in this trial
Questcor Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers